triphenylphosphine has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Gong, S; Guan, X; Huang, Y; Li, Y; Liao, S; Liu, C; Liu, Y; Qin, S; Shen, Y; Xin, W; Xiong, J; Yao, M; Zhao, J | 1 |
1 other study(ies) available for triphenylphosphine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy.
Topics: Acute Kidney Injury; Animals; Membrane Proteins; Mice; Mitochondrial Proteins; Mitophagy; Renal Insufficiency, Chronic; Zebrafish | 2023 |